1. Home
  2. USAS vs TVTX Comparison

USAS vs TVTX Comparison

Compare USAS & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$5.61

Market Cap

3.2B

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$31.48

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAS
TVTX
Founded
1998
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.3B
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
USAS
TVTX
Price
$5.61
$31.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
14
Target Price
$4.08
$36.62
AVG Volume (30 Days)
5.9M
1.0M
Earning Date
03-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.89
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$145.86
$44.62
Revenue Next Year
$31.99
$31.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$12.91
52 Week High
$10.50
$42.13

Technical Indicators

Market Signals
Indicator
USAS
TVTX
Relative Strength Index (RSI) 40.74 63.14
Support Level $4.85 $30.92
Resistance Level $6.24 $33.14
Average True Range (ATR) 0.56 1.24
MACD -0.16 0.46
Stochastic Oscillator 30.01 96.79

Price Performance

Historical Comparison
USAS
TVTX

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: